Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000895345-02-000250
Filing Date
2002-05-10
Accepted
2002-05-10 17:18:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 jbdefa14a33.txt DEFA14A 68638
  Complete submission text file 0000895345-02-000250.txt   70102
Mailing Address 3300 HYLAND AVE COSTA MESA CA 92626
Business Address 3300 HYLAND AVE COSTA MESA CA 92626 7145450100
ICN PHARMACEUTICALS INC (Filer) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-11397 | Film No.: 02642325
SIC: 2834 Pharmaceutical Preparations